655 related articles for article (PubMed ID: 11920888)
1. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21.
Souter VL; Nyberg DA; El-Bastawissi A; Zebelman A; Luthhardt F; Luthy DA
Prenat Diagn; 2002 Mar; 22(3):175-82. PubMed ID: 11920888
[TBL] [Abstract][Full Text] [Related]
2. Correlation of second-trimester sonographic and biochemical markers.
Souter VL; Nyberg DA; Benn PA; Zebelman A; Luthardt F; Luthy DA
J Ultrasound Med; 2004 Apr; 23(4):505-11. PubMed ID: 15098869
[TBL] [Abstract][Full Text] [Related]
3. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
4. Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21.
Borrell A; Mercade I; Casals E; Borobio V; Seres A; Soler A; Fortuny A; Cuckle H
Ultrasound Obstet Gynecol; 2007 Dec; 30(7):941-5. PubMed ID: 18000942
[TBL] [Abstract][Full Text] [Related]
5. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
6. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
7. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
8. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
9. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Hu Z; Liu X; Li L; Jia C; Li D; Liu R
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
[TBL] [Abstract][Full Text] [Related]
10. Cystic hygroma and mid-trimester maternal serum screening.
Celentano C; Prefumo F; Iezzi I; Guanciali-Franchi PE; Palka C; Liberati M; Rotmensch S
J Med Screen; 2007; 14(3):109-12. PubMed ID: 17925081
[TBL] [Abstract][Full Text] [Related]
11. Extreme second-trimester serum analyte values in down syndrome pregnancies with hydrops fetalis.
Benn PA; Egan JF; Ingardia CJ
J Matern Fetal Neonatal Med; 2002 Apr; 11(4):262-5. PubMed ID: 12375682
[TBL] [Abstract][Full Text] [Related]
12. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
13. Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013).
; Prabhu M; Kuller JA; Biggio JR
Am J Obstet Gynecol; 2021 Oct; 225(4):B2-B15. PubMed ID: 34171388
[TBL] [Abstract][Full Text] [Related]
14. Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome.
Lam YH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF; Fong DY; Tang MH; Woo HH
Prenat Diagn; 2002 Aug; 22(8):730-5. PubMed ID: 12210586
[TBL] [Abstract][Full Text] [Related]
15. Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects.
Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ
Prenat Diagn; 2009 Jun; 29(6):570-7. PubMed ID: 19266536
[TBL] [Abstract][Full Text] [Related]
16. Using second trimester ultrasound and maternal serum biomarker data to help detect congenital heart defects in pregnancies with positive triple-marker screening results.
Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ
Am J Med Genet A; 2008 Oct; 146A(19):2455-67. PubMed ID: 18785270
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of ultrasound markers in screening fetal trisomy 21].
Shi XM; Fang Q; Chen BJ; Xie HN; Xie YJ; Chen JH; Wu JZ
Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):81-5. PubMed ID: 23544486
[TBL] [Abstract][Full Text] [Related]
18. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks.
Cicero S; Bindra R; Rembouskos G; Spencer K; Nicolaides KH
Prenat Diagn; 2003 Apr; 23(4):306-10. PubMed ID: 12673635
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Rice JD; McIntosh SF; Halstead AC
Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
[TBL] [Abstract][Full Text] [Related]
20. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]